Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 246 participants.

Also called NCT06980753

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 246 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06980753
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06980753. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-06-01 (anticipated); primary completion 2025-11-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders
Condition
Cushing Syndrome
Condition
Primary Aldosteronism
Condition
Adrenal Insufficiency
Intervention (Device)
Participants will use the biossensor for 48 h
Lead sponsor
University of Sao Paulo General Hospital (class: other)
Collaborator
Swiss Federal Institute of Technology in Zurich (ETH Zurich) (class: not stated)
Collaborator
Fundação de Amparo à Pesquisa do Estado de São Paulo (class: other government)

Record details

Record id
cardio:ct-nct06980753
Content hash
b0eb563eccc1c10b39790b622d915abbbf077ad3d7de319618cc332cd6594df3